BDX — Becton Dickinson and Company · P/E 34, rev $21.84B

Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.

Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. BDX currently screens at market cap $50.30B and trailing P/E 33.9.

Use this BDX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the BDX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the BDX SEC filings page. Lician reads the product cache first so this HTML stays unique to Becton Dickinson and Company even when a live quote feed is slow.